"10.1371_journal.pone.0116407","plos one","2015-02-25T00:00:00Z","L Eugene Arnold; Paul Hodgkins; Hervé Caci; Jennifer Kahle; Susan Young","Research Unit on Pediatric Psychopharmacology, The Ohio State University, Columbus, Ohio, United States of America; Global Health Economics & Outcomes Research, Shire, Wayne, PA, United States of America; Hôpitaux Pédiatriques de Nice CHU Lenval, F-06200, Nice, France; BPS International, San Diego, CA, 92130, United States of America; Imperial College London, Centre for Mental Health, London, SW7 2AZ, United Kingdom","Conceived and designed the experiments: LEA PH HC JK SY. Performed the experiments: JK. Analyzed the data: JK. Wrote the paper: LEA PH HC JK SY. Approval of final manuscript: LEA PH HC JK SY.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: Dr. Arnold has received research funding from Curemark, Lilly, Forest, and Shire; advisory board honoraria from Astra-Zeneca, Biomarin, Noven, Otsuka, Roche, Seaside Therapeutics, and Shire; consulting fees from Tris Pharma, Gowlings, and Pfizer; and travel support from Noven (nothing for contributing to this article). At the time this analysis was performed and the manuscript written, Dr. Hodgkins was an employee of Shire Development LLC, owned Shire stock, and had Shire stock options. Dr. Caci has received consulting fees from Shire (nothing for contributing to this article). Dr. Kahle is owner of BPS International, which received consultancy fees from Shire Development LLC for this and previous research. Dr. Young has received research funding or consulting fees from Janssen-Cilag, Eli-Lilly, Novartis, Flynn-Pharma, and Shire (nothing for contributing to this article). She was a member of the United Kingdom NICE Guideline Development Group for ADHD and is a consultant at the Cognitive Centre of Canada. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","02","L Eugene Arnold","LEA",5,TRUE,5,1,1,5,TRUE,FALSE,FALSE,0,NA,FALSE
